Atlas Venture
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
- Germany
- Austria
- Switzerland
- Sweden
- United Kingdom
- Belgium
- Denmark
- Netherlands
- USA
- Canada
- Finland
- Estonia
- Latvia
- Lithuania
- Luxembourg
- Spain
- Czech Republic
- France
- Hungary
- Iceland
- New Zealand
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Fintech
- AI
- Health Tech
- Data Science
About
Atlas Venture specializes in investing in early-stage life sciences innovation by partnering with entrepreneurs to create breakthrough biotechnology companies.
Atlas Venture specializes in investing in early-stage life sciences innovation by partnering with entrepreneurs to create breakthrough biotechnology companies.
Investment Thesis
Atlas Venture focuses on creating and building breakthrough biotechnology companies. They partner with life science entrepreneurs to translate innovation into novel medicines, emphasizing a collaborative, sciencefirst, patientcentric culture.
Manager's Experience
Focused on early-stage investments across technology and healthcare sectors. With deep experience in the North American market, successfully closed over 50 deals with a notable number of exits. Specializes in growth equity, employing a hands-on approach to drive operational improvements. Recognized for a robust track record in fostering innovation and delivering exceptional returns.
Team
Tandee Newman
Steven Robinette
Sarah Coughlin
Sarah Gerrish
Sarah Coughlin
Rajesh Devraj
Philip Austin
Peter Barrett
Ommer Chohan
Michael Gladstone